Clinical evaluations of a comprehensive range of inhaler systems, e.g. pMDI, DPI, nebulisers (air-jet, ultrasonic, and vibrating mesh) and novel delivery systems are routinely performed.

Scintigraphic imaging has also been combined with pharmacokinetic analysis to provide a more powerful understanding of the link between the in vivo deposition and fate of dosage forms and the ensuing drug bioavailability.

i2c offers independent advice and input into the design and development of protocols for in vitro and clinical studies. This can be supported with rapid analysis, interpretation and reporting of study data.

i2c also offers independent review and due diligence, clinical report writing in accordance with ICH guidelines, and preparation of scientific articles, e.g. abstracts, posters and publications.